David L. Williams

Dr. David L. Williams

orcid

Research Focus & Metrics

Academic Career Length

32Years (1995-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2013 in Antioxidants & Redox Signaling
Verified
Journal Article
Closed access
DWDavid L. Williams
David L. Williams
MBMariana Bonilla
Mariana Bonilla
VGVadim N. Gladyshev
Vadim N. Gladyshev
GSGustavo Salinas
Gustavo Salinas
Significance: Platyhelminth parasites cause chronic infections that are a major cause of disability, mortality, and economic losses in developing countries. Maintaining redox homeostasis is a major adaptive problem faced by parasites and its disruption can shift the biochemical balance toward the host. Platyhelminth parasites possess a streamlined thiol-based redox system in which a single enzyme, thioredoxin glutathione reductase (TGR), a fusion of a glutaredoxin (Grx) domain to canonical thioredoxin reductase (TR) domains, supplies electrons to oxidized glutathione (GSSG) and thioredoxin (Trx). TGR has been validated as a drug target for schistosomiasis. Recent Advances: In addition to glutathione (GSH) and Trx reduction, TGR supports GSH-independent deglutathionylation conferring an additional advantage to the TGR redox array. Biochemical and structural studies have shown that the TR activity does not require the Grx domain, while the glutathione reductase and deglutathionylase activities depend on the Grx domain, which receives electrons from the TR domains. The search for TGR inhibitors has identified promising drug leads, notably oxadiazole N-oxides. Critical Issues: A conspicuous feature of platyhelminth TGRs is that their Grx-dependent activities are temporarily inhibited at high GSSG concentrations. The mechanism underlying the phenomenon and its biological relevance are not completely understood. Future Directions: The functional diversity of Trxs and Grxs encoded in platyhelminth genomes remains to be further assessed to thoroughly understand the TGR-dependent redox network. Optimization of TGR inhibitors and identification of compounds targeting other parasite redox enzymes are good options to clinically develop relevant drugs for these neglected, but important diseases. Antioxid. Redox Signal. 19, 735–745.

1 December 2011 in Biochimica et Biophysica Acta (BBA) - General Subjects
Verified
Journal Article
Closed access
SPStefanie Prast-Nielsen
Stefanie Prast-Nielsen
HHHsin-Hung Huang
Hsin-Hung Huang
DWDavid L. Williams
David L. Williams

1 July 2011 in Molecular and Biochemical Parasitology
Verified
Journal Article
Closed access
ACAlexis A. Cogswell
Alexis A. Cogswell
JCJames J. Collins
James J. Collins
PNPhillip A. Newmark
Phillip A. Newmark
DWDavid L. Williams
David L. Williams

17 September 2009 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
GRGanesha Rai
Ganesha Rai
ASAhmed A. Sayed
Ahmed A. Sayed
WLWendy A. Lea
Wendy A. Lea
HLHans F. Luecke
Hans F. Luecke
HCHarinath Chakrapani
Harinath Chakrapani
CTCraig J. Thomas
Craig J. Thomas

1 September 2014 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
SGStefano Guglielmo
Stefano Guglielmo
DCDaniela Cortese
Daniela Cortese
FVFrancesca Vottero
Francesca Vottero
BRBarbara Rolando
Barbara Rolando
VKValerie P. Kommer
Valerie P. Kommer
AGAlberto Gasco
Alberto Gasco

1 June 2011 in Biochemistry
Verified
Journal Article
Closed access
HHHsin-Hung Huang
Hsin-Hung Huang
LDLatasha Day
Latasha Day
CCCynthia L. Cass
Cynthia L. Cass
DBDavid P. Ballou
David P. Ballou
CWCharles H. Williams
Charles H. Williams
DWDavid L. Williams
David L. Williams